ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Inhibrx Biosciences, Inc.
15.86
0.0000
成交量：
- -
成交額：
1,097.66萬
市值：
2.26億
市盈率：
- -
高：
15.86
開：
15.86
低：
15.86
收：
15.86
52周最高：
15.86
52周最低：
15.86
股本：
1,424.00萬
流通股本：
1,424.00萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Inhibrx Biosciences, Inc.盤中異動 下午盤股價大漲5.39%
市场透视
·
2025/08/21
Inhibrx Biosciences, Inc.盤中異動 下午盤股價大跌5.46%報22.94美元
市场透视
·
2025/07/31
Inhibrx Biosciences, Inc.盤中異動 臨近午盤快速下挫5.26%
市场透视
·
2025/07/29
Inhibrx Biosciences, Inc.盤中異動 股價大漲5.11%
市场透视
·
2025/07/28
Inhibrx Biosciences, Inc.盤中異動 早盤股價大跌5.20%
市场透视
·
2025/07/25
Inhibrx Biosciences, Inc.盤中異動 下午盤急速下挫5.69%
市场透视
·
2025/07/22
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/INXB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INXB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences, Inc.","latestPrice":15.86,"timestamp":1717099200000,"preClose":15.86,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":14240000,"shares":14240000,"eps":0,"marketStatus":"盤前交易","change":0,"latestTime":"03-24 04:14:43 EDT","open":15.86,"high":15.86,"low":15.86,"amount":10976590.3275,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"INBX","executeDate":"2024-05-31"},"adr":0,"exchange":"NASDAQ","adjPreClose":15.86,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INXB\",,,,,undefined,":{"symbol":"INXB","floatShares":14240000,"roa":"--","roe":"--","lyrEps":0,"shares":14240000,"dividePrice":0,"high":15.86,"amplitude":0,"preClose":15.86,"low":15.86,"week52Low":15.86,"pbRate":"--","week52High":15.86,"institutionHeld":0,"latestPrice":15.86,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":15.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INXB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-31","symbol":"INXB","oldSymbol":"INXB","defaultRemindTime":1717162200000,"newSymbol":"INBX","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1717128000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INXB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INXB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1723608000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INXB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561486216","title":"Inhibrx Biosciences, Inc.盤中異動 下午盤股價大漲5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561486216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561486216?lang=zh_tw&edition=fundamental","pubTime":"2025-08-21 03:13","pubTimestamp":1755717201,"startTime":"0","endTime":"0","summary":"北京时间2025年08月21日03时13分，Inhibrx Biosciences, Inc.股票出现异动，股价快速拉升5.39%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Radiopharm Theranostics Limited涨幅较大，Tharimmune, Inc.、Novabay Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5449.39%、2844.17%、466.86%，振幅较大的相关个股有Tharimmune, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Windtree Therapeutics, Inc.，振幅分别为192.31%、100.00%、81.79%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082103132194f0636d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082103132194f0636d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139","INXB"],"gpt_icon":0},{"id":"2555290590","title":"Inhibrx Biosciences, Inc.盤中異動 下午盤股價大跌5.46%報22.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555290590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555290590?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 03:22","pubTimestamp":1753903353,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时22分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下跌5.46%。截至发稿，该股报22.94美元/股，成交量5.0501万股，换手率0.35%，振幅7.01%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032233a46c06ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731032233a46c06ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139","INXB"],"gpt_icon":0},{"id":"2555006841","title":"Inhibrx Biosciences, Inc.盤中異動 臨近午盤快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555006841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555006841?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 23:55","pubTimestamp":1753804502,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时55分，Inhibrx Biosciences, Inc.股票出现异动，股价急速跳水5.26%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292355039725bcb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507292355039725bcb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INXB","BK4139","INBX"],"gpt_icon":0},{"id":"2554777534","title":"Inhibrx Biosciences, Inc.盤中異動 股價大漲5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554777534?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 21:56","pubTimestamp":1753710974,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时56分，Inhibrx Biosciences, Inc.股票出现波动，股价大幅拉升5.11%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215614972356a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215614972356a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INXB","BK4139","INBX"],"gpt_icon":0},{"id":"2554793983","title":"Inhibrx Biosciences, Inc.盤中異動 早盤股價大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554793983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554793983?lang=zh_tw&edition=fundamental","pubTime":"2025-07-25 21:40","pubTimestamp":1753450855,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日21时40分，Inhibrx Biosciences, Inc.股票出现波动，股价急速下跌5.20%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214055a4637d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725214055a4637d2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","INXB","BK4139"],"gpt_icon":0},{"id":"2553406354","title":"Inhibrx Biosciences, Inc.盤中異動 下午盤急速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553406354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553406354?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 02:01","pubTimestamp":1753120879,"startTime":"0","endTime":"0","summary":"北京时间2025年07月22日02时01分，Inhibrx Biosciences, Inc.股票出现波动，股价急速跳水5.69%。Inhibrx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Inhibrx Biosciences, Inc.公司简介：Inhibrx Biosciences Inc是一家临床阶段的生物制药公司，利用其专有的模块化蛋白质工程平台开发了一系列新型生物治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722020119a45a460b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722020119a45a460b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INBX","BK4139","INXB"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}